Volume : 10, Issue : 12, December – 2023
Title:
MOLECULAR DYNAMIC SIMULATION – BASED PHYTOCHEMICAL SCREENING OF BUCKWHEAT (Fagopyrum esculentum) LEAF EXTRACT AGAINST CANCER BY TARGETING HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR
Authors :
Dr. S. Swarnalatha, V.Vikram*, R.Thamarainayaki,B.Umesh Narayan, B. Yuvaraj
Abstract :
Fagopyrum esculentum, a member of the polygonaceae family, is commonly found in India and is known for its anticancer leaves. It is used to treat ulcers, peridontitis, anemia, constipation, and hemostasis. Fagopyrum esculentum is a complete treatment that can be used for lung cancer. Unknown is the exact chemical process that underlies buckwheat’s anticancer properties. The Protein Data Bank was used to collected the crystal structure of the human epidermal growth factor receptor. Lung cancer cell growth was markedly inhibited and changed when the active components of Fagopyrum esculentum (rutin, vitexin, and quercetin) were molecularly docked with lung cancer protein. This experiment indicates that Fagopyrum esculentum can prevent lung cancer. The study’s conclusions offer significant new data.
KEYWORDS: Fagopyrum esculentum, Rutin,Vitexin, Quercetin and Human Epidermal Growth Factor Receptor
Cite This Article:
Please cite this article in press V.Vikram et al., Molecular Dynamic Simulation – Based Phytochemical Screening Of Buckwheat (Fagopyrum Esculentum) Leaf Extract Against Cancer By Targeting Human Epidermal Growth Factor Receptor, Indo Am. J. P. Sci, 2023; 10 (12).
Number of Downloads : 10
References:
1. Donna S. Shewach Guest Editor, University of Michigan School of Medicine Robert D. Kuchta Issue Editor, University of Colorado, Boulder CR900208X.
2. Abbasi R, Janjua S, Rehman A, William K, Khan SW. Some preliminary studies on phytochemichals and antioxidant potential of Fagopyrum esculentum cultivated in Chitral, Pakistan. The Journal of Animal & Plant Sciences. 2015 Jan 1;25(3):576-9.
3. Al-Snafi AE. A review on Fagopyrum esculentum: A potential medicinal plant. IOSR Journal of Pharmacy. 2017 Mar;7(3):21-32. Parkin D.M.Bray F.I.Devesa S.S.Cancer burden in the year 2000. The global picture.Eur. J. 2001; Cancer 37: 4-66.
4. Parkin D.M.Bray F.I.DevesaS.S.Cancer burden in the year 2000. The global picture.Eur. J. 2001; Cancer 37: 4-66
5. Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nature Reviews Clinical Oncology. 2023 Sep;20(9):624-39.
6. Morris GM, Lim-Wilby M. Molecular docking. Molecular modeling of proteins. 2008:365-82.
7. Cersosimo RJ. Lung cancer: a review. American Journal of Health-System Pharmacy. 2002 Apr 1;59(7):611-42.
8. Patz Jr EF, Goodman PC, Bepler G. Screening for lung cancer. New England Journal of Medicine. 2000 Nov 30;343(22):1627-33.
9. Field RW, Withers BL. Occupational and environmental causes of lung cancer. Clinics in chest medicine. 2012 Dec 1;33(4):681-703.